Literature DB >> 17762946

Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy.

Rolf Fronczek, Jan Verschuuren, Gert Jan Lammers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17762946     DOI： 10.1007/s00415-007-0594-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.

Authors:  Michel Lecendreux; Stephanie Maret; Claudio Bassetti; Marie-Christine Mouren; Mehdi Tafti
Journal:  J Sleep Res       Date:  2003-12       Impact factor: 3.981

2.  Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.

Authors:  John Logan Black; Lois E Krahn; V Shane Pankratz; Michael Silber
Journal:  Sleep       Date:  2002-11-01       Impact factor: 5.849

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.

Authors:  Sebastiaan Overeem; Jan J Verschuuren; Rolf Fronczek; Liesbeth Schreurs; Heleen den Hertog; Ingrid M Hegeman-Kleinn; Sjoerd G van Duinen; Unga A Unmehopa; Dick F Swaab; Gert Jan Lammers
Journal:  J Neuroimmunol       Date:  2006-03-06       Impact factor: 3.478

5.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

6.  Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.

Authors:  Yves Dauvilliers; Bertrand Carlander; François Rivier; Jacques Touchon; Mehdi Tafti
Journal:  Ann Neurol       Date:  2004-12       Impact factor: 10.422

7.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.

Authors:  E Mignot; L Lin; W Rogers; Y Honda; X Qiu; X Lin; M Okun; H Hohjoh; T Miki; S Hsu; M Leffell; F Grumet; M Fernandez-Vina; M Honda; N Risch
Journal:  Am J Hum Genet       Date:  2001-02-13       Impact factor: 11.025

8.  Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.

Authors:  Marketa Hecht; Ling Lin; Clete A Kushida; Dale T Umetsu; Shahrad Taheri; Mali Einen; Emmanuel Mignot
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  Determining optimal therapy--randomized trials in individual patients.

Authors:  G Guyatt; D Sackett; D W Taylor; J Chong; R Roberts; S Pugsley
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245
  9 in total
  17 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

3.  Immunoadsorption for the treatment of narcolepsy with cataplexy.

Authors:  Alessandro Pincherle; Flavio Villani; Luigi Ferini Strambi; Maria Livia Fantini; Suela Dylgjeri; Roberto Spreafico; Carlo Antozzi
Journal:  Neurol Sci       Date:  2008-12-05       Impact factor: 3.307

4.  No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.

Authors:  Philipp O Valko; Ramin Khatami; Christian R Baumann; Claudio L Bassetti
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

Review 5.  Current treatment of selected pediatric sleep disorders.

Authors:  Shannon S Sullivan
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

6.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 7.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

8.  Recent advances in the treatment of narcolepsy.

Authors:  Nobuhide Hirai; Seiji Nishino
Journal:  Curr Treat Options Neurol       Date:  2011-10       Impact factor: 3.598

Review 9.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

10.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Francesca Poli; Christian Franceschini; Antonia Parmeggiani; Piero Pirazzoli; Filippo Bernardi; Emmanuel Mignot; Alessandro Cicognani; Pasquale Montagna
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.